Company News
Advanced gene delivery system secures Japan patent
Jan 17 2024
ProBioGen has announced that the Japan Patent Office (JPO) has granted the first patent for the company’s DirectedLuck® technology. This advanced gene delivery system is anchored in a highly potent transposase fusion variant, facilitating epigenetic targeting alongside a meticulously designed transposon.
Dr Volker Sandig, Chief Scientific Officer of ProBioGen, emphasised the significance of this patent grant for the ground-breaking cell-engineering technology. The plug-and-play system offers advantages throughout the biopharmaceutical value chain, enabling accelerated timelines for clinical applications. Dr Sandig stated: ‘‘Thanks to our DirectedLuck® technology, clients attain higher titres and maximum stability within condensed timelines.’’
ProBioGen has successfully implemented DirectedLuck® to generate numerous producer cell lines for clients, garnering endorsement from ProBioGen’s licensees. Beyond its application in generating producer cell lines, DirectedLuck® proves versatile for creating stable packaging cell lines for viral vectors and finds utility in gene and cell therapy.
More information online
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan